Michael S Sinha1, John C Messinger1, Leo Beletsky1. 1. Michael S. Sinha, M.D., J.D., M.P.H., is a Research Fellow at the Harvard-MIT Center for Regulatory Science at Harvard Medical School, an Affiliated Researcher at the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, and a Visiting Scholar at the Center for Health Policy and Law at Northeastern University School of Law, all in Boston, Massachusetts, United States. John C. Messinger, B.S., is a Medical Student at Harvard Medical School in Boston, Massachusetts, United States. Leo Beletsky, J.D., M.P.H., is a Professor of Law and Health Sciences at Northeastern University, Boston, Massachusetts, United States, where he also directs the Health in Justice Action Lab. He is also an Associate Adjunct Professor in the Division of Infectious Disease and Global Public Health at UC San Diego School of Medicine, La Jolla, California, United States.
Authors: Anh T Vo; Christopher Magana; Matthew Hickman; Annick Borquez; Leo Beletsky; Natasha K Martin; Javier A Cepeda Journal: Int J Drug Policy Date: 2021-08-11